Celularity Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +28.9% | +0.0% | +287.8% | -17.5% | -23.2% | +95.1% | +0.0% | -68.4% | -7.9% | -22.3% | +0.0% | – | |
| – | +349.1% | +0.0% | -54.5% | +485.9% | -59.6% | +89.1% | +0.0% | -28.6% | -61.5% | +265.4% | -160.4% | – | |
| – | -91.4% | +0.0% | +6,987.5% | -80.8% | +116.3% | +99.3% | +0.0% | -95.4% | +561.1% | -200.1% | – | – | |
| – | -39.8% | +0.0% | +12.8% | +1,749.6% | -96.4% | -2.2% | +0.0% | -12.4% | +37.2% | -27.2% | +0.0% | – | |
| – | -16.2% | +21.6% | +7.3% | -7.2% | -2.9% | +26.9% | -0.1% | -21.2% | -26.3% | +61.9% | – | – | |
| – | -55.0% | +395.1% | -77.8% | -149.0% | – | +63.0% | -27.3% | -18.5% | -1.2% | +61.8% | +17.0% | – | |
| – | – | – | – | – | -186.6% | – | – | – | – | – | – | – | |
| – | -12.0% | +0.0% | +18.2% | -42.2% | +164.3% | +3.4% | +0.0% | +7.2% | -24.0% | -39.3% | +0.0% | – | |
| – | – | – | – | – | -268.4% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -134,990.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -268.6% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.